
Insignia Health
Advertisement
Articles by Insignia Health


*** Thursday, May 20, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST *** What if you had a way to determine with more certainty who would stick with a clinical trial or patient support program? Patient activation holds the key to selection refinement and cost efficiency. ***On demand available after final airing until May 20, 2022***
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER
3
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
4
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
5
